Nerve gases are a class of phosphorus based organic chemicals that disrupts the biological mechanism through which nerves present in the brain transfer messages and instructions to various organs of the body. The disturbance is caused due to the blockage of a neurotransmitter called acetylcholinesterase. Poisoning by nerve gases and pesticides leads to various medical complications such as convulsions, contractions of pupils, profuse salivation, involuntary defecation and death. 
 
There are two main classes of nerve gas and agents, which are usually used in military warfare:
  • G – series, a class of non persistent toxic chemical substances. The nerve agents belonging to this group are:
    • GA (Tabun)
    • GB (Sarin)
    • GD (Soman)
    • GF (Cyclosarin)
  • V – series, a class of organophosphate compounds persistent in nature. The nerve agents belonging to this class are:
    • VE
    • VG (Tetram)
    • VM (Edemo)
    • VR (Russian VX, Soviet V-gas, Substance 33, R-33)
    • VX (nerve agent)
Some of the drugs usually used in the treatment of nerve gas and pesticide poisoning are as follows:
  • Anticholinergic agents
    • Atropine IV/IM
    • Glycopyrrolate
  • Pralidoxime chloride
  • Benzodiazepines
    • Diazepam
  • Butyrylcholinesterase
In terms of geography, nerve gas and pesticide poisoning is not prevalent in any specific regions. It has also been observed that nerve agent exposure is exceptionally rare in the U.S. Thus, the market growth of the drugs for treating nerve gas and pesticide poisoning might be sluggish in this region. However, despite implementation of stringent regulatory policies to control the propagation of chemical weapons, nerve gas agents are still stored by the military of several countries such as Iraq, Sudan, Japan and North Korea. To date there is no large scale military deployment of nerve gas and pesticide poisons during wars, but if the use of chemical weapons increases then there are chances that the antidote for these chemicals might experience an exceptional growth across the globe. 
 
Some of the major factors driving the growth of Nerve Gas & Pesticide Poisoning market are increasing incidence rate of biological and chemical warfare along with high usage of toxic chemicals in the weapons and artilleries. Moreover, frequent riots in countries such as Iraq, Afghanistan, Iran, Somalia and Sudan is expected to propel the market for nerve gas & pesticide poisoning to a remarkable extent. Furthermore, frequent outbreak of civil wars such as South Sudanese Civil War (2013), Pro-Russian unrest in Ukraine (2014) and internal conflict in Mozambique (2013) are expected to boost the development of antidotes for chemical weapons; which will alternatively drive the sales of nerve gas treatment agents especially in these regions. However, narrow distribution channels and stringent regulatory approvals for these antidotes are few factors that might negatively affect the growth of this market.  
 
At present, the global nerve gas & pesticide poisoning market is a highly consolidated market. Development of products for treating nerve gas & pesticide poisoning market is highly critical and expensive, so only a few players have entered into the market. However, it is expected that in due course of time other companies will try to penetrate in this industry owing to the high incidence rate of biological warfare. Some of the companies involved with the development of drugs for treating nerve gas & pesticide poisoning are Baxter International, Inc., Meridian Medical Technologies, Inc., MicroDose Therapeutx, Inc., PharmAthene, Inc., Protalix BioTherapeutics, Inc. and Teva Pharmaceutical Industries Ltd., amongst others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Nerve Gas Pesticide Poisoning